Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Surg.

Sec. Surgical Oncology

Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1618111

This article is part of the Research TopicSurgical Management and Outcomes for Gastric CancerView all 3 articles

Prognostic Value of Prognostic Nutritional Index in Patients Undergoing Surgery for Gastric Cancer

Provisionally accepted
Fırat  MülkütFırat Mülküt1*Cem  Batuhan OfluoğluCem Batuhan Ofluoğlu1Mustafa  Kağan BaşdoğanMustafa Kağan Başdoğan1İsa  Caner Aydınİsa Caner Aydın2Osman  AkdoğanOsman Akdoğan3Adnan  GündoğduAdnan Gündoğdu1İsmail  Ege Subaşıİsmail Ege Subaşı1
  • 1Martyr Dr. İlhan Varank Sancaktepe Training and Research Hospital, Dudullu, Türkiye
  • 2Zonguldak Atatürk State Hospital, Zonguldak, Zonguldak, Türkiye
  • 3Ministiry of Health, Keşan State Hospital, Edirne, Türkiye

The final, formatted version of the article will be published soon.

Background and Aim: Gastric cancer is among the commonly occurring cancers worldwide and is one of the leading causes of cancer-related deaths. Malnutrition is an important factor affecting the course of disease and treatment response in gastric cancer patients This study aimed to investigate the effect of the Prognostic Nutritional Index (PNI) on postoperative complications and long-term survival in gastric cancer patients, and to comparatively examine PNI values among different histological subtypes. Methods: Data from patients who underwent curative surgical resection for gastric cancer between 2014 and 2020 were retrospectively analyzed. PNI values were calculated using the formula: 10 × serum albumin (g/dL) + 0.005 × lymphocyte count (cells/mm³). The optimal cut-off value for PNI was determined through ROC analysis. The relationship between PNI values and clinicopathological features, postoperative complications, 5-year overall survival (OS), and histological subtypes was evaluated. Results: A total of 220 patients (161 males, 59 females; mean age: 60.63±10.56) were included in the study. The mean PNI value was 47.15±6.07. ROC analysis established an optimal PNI cut-off value of 46.2 (AUC=0.673, 95% CI: 0.599-0.747, p<0.001; sensitivity 78.8%, specificity 51.9%). Complication rates were significantly higher in the patient group with PNI<46.2 (p=0.006). The 5-year OS rate was 30.0%. Patients with low PNI values had significantly shorter survival (log-rank p=0.001). Major complications were more frequent in patients with low PNI (p=0.006). Patients diagnosed with signet ring cell carcinoma (SRCC) had significantly lower PNI values compared to other adenocarcinoma subtypes (p=0.001). PNI values were lower in the presence of perineural invasion (p=0.005) and lymphovascular invasion (p=0.032). In multivariate analysis, tumor stage (for Stage I p=0.01, Stage II p=0.034, Stage III p=0.002) and PNI value (p=0.001) were identified as independent prognostic factors affecting 5-year OS. Conclusion: PNI is an important marker for predicting long-term survival and postoperative complication risk in patients with gastric cancer. The significantly lower PNI values in the SRCC subtype compared to other histological subtypes indicate the necessity of closer monitoring of nutritional status in this patient group. Our results suggest that preoperative PNI assessment could be a valuable parameter in planning patient-specific treatment approaches.

Keywords: gastric cancer, Prognostic nutritional index (PNI), signet cell gastric carcinoma, Survival, Post-operative outcomes

Received: 25 Apr 2025; Accepted: 14 Aug 2025.

Copyright: © 2025 Mülküt, Ofluoğlu, Başdoğan, Aydın, Akdoğan, Gündoğdu and Subaşı. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Fırat Mülküt, Martyr Dr. İlhan Varank Sancaktepe Training and Research Hospital, Dudullu, Türkiye

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.